These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11899237)

  • 21. A novel glutamine-RNA interaction identified by screening libraries in mammalian cells.
    Tan R; Frankel AD
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4247-52. PubMed ID: 9539722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Merged screening for human immunodeficiency virus Tat and Rev inhibitors.
    Hamy F; Felder E; Lipson K; Klimkait T
    J Biomol Screen; 2001 Jun; 6(3):179-87. PubMed ID: 11689114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RNA binding by the tat and rev proteins of HIV-1.
    Karn J; Dingwall C; Finch JT; Heaphy S; Gait MJ
    Biochimie; 1991 Jan; 73(1):9-16. PubMed ID: 1903308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of primary human T cells from HIV infection by Trev: a transdominant fusion gene.
    Chinen J; Aguilar-Cordova E; Ng-Tang D; Lewis DE; Belmont JW
    Hum Gene Ther; 1997 May; 8(7):861-8. PubMed ID: 9143912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression kinetics and subcellular localization of HIV-1 regulatory proteins Nef, Tat and Rev in acutely and chronically infected lymphoid cell lines.
    Ranki A; Lagerstedt A; Ovod V; Aavik E; Krohn KJ
    Arch Virol; 1994; 139(3-4):365-78. PubMed ID: 7832642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A docking and modelling strategy for peptide-RNA complexes: applications to BIV Tat-TAR and HIV Rev-RBE.
    Srinivasan J; Leclerc F; Xu W; Ellington AD; Cedergren R
    Fold Des; 1996; 1(6):463-72. PubMed ID: 9080192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rev-dependent expression of three species of HIV-1 mRNAs (review).
    Fukumori T; Kagawa S; Iida S; Oshima Y; Akari H; Koyama AH; Adachi A
    Int J Mol Med; 1999 Mar; 3(3):297-302. PubMed ID: 10028055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rev-mediated nuclear export of RNA is dominant over nuclear retention and is coupled to the Ran-GTPase cycle.
    Fischer U; Pollard VW; Lührmann R; Teufel M; Michael MW; Dreyfuss G; Malim MH
    Nucleic Acids Res; 1999 Nov; 27(21):4128-34. PubMed ID: 10518602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins.
    Pritchard CE; Grasby JA; Hamy F; Zacharek AM; Singh M; Karn J; Gait MJ
    Nucleic Acids Res; 1994 Jul; 22(13):2592-600. PubMed ID: 8041622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminoglycoside antibiotics, neamine and its derivatives as potent inhibitors for the RNA-protein interactions derived from HIV-1 activators.
    Hamasaki K; Ueno A
    Bioorg Med Chem Lett; 2001 Feb; 11(4):591-4. PubMed ID: 11229778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regulatory mechanism of HIV gene expression].
    Hatanaka M
    Nihon Rinsho; 1993 Sep; 51 Suppl():43-57. PubMed ID: 8271415
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV regulatory proteins: potential targets for therapeutic intervention.
    Rosen CA
    AIDS Res Hum Retroviruses; 1992 Feb; 8(2):175-81. PubMed ID: 1540405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tat and Rev: positive regulators of HIV gene expression.
    Rosen CA; Pavlakis GN
    AIDS; 1990 Jun; 4(6):499-509. PubMed ID: 2201316
    [No Abstract]   [Full Text] [Related]  

  • 34. The post-transcriptional regulator Rev of HIV: implications for its interaction with the nucleolar protein B23.
    Miyazaki Y; Nosaka T; Hatanaka M
    Biochimie; 1996; 78(11-12):1081-6. PubMed ID: 9150888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure of simian immunodeficiency virus regulatory genes.
    Colombini S; Arya SK; Reitz MS; Jagodzinski L; Beaver B; Wong-Staal F
    Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4813-7. PubMed ID: 2544874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral effects of human immunodeficiency virus type 1-specific small interfering RNAs against targets conserved in select neurotropic viral strains.
    Dave RS; Pomerantz RJ
    J Virol; 2004 Dec; 78(24):13687-96. PubMed ID: 15564478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA molecule.
    Lisziewicz J; Zeng G; Gratas C; Weinstein JN; Lori F
    Hum Gene Ther; 2000 Apr; 11(6):807-15. PubMed ID: 10779158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene transactivation mediated by the TAT gene of human immunodeficiency virus in transgenic mice.
    Khillan JS; Deen KC; Yu SH; Sweet RW; Rosenberg M; Westphal H
    Nucleic Acids Res; 1988 Feb; 16(4):1423-30. PubMed ID: 3258064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology.
    Emerman M; Malim MH
    Science; 1998 Jun; 280(5371):1880-4. PubMed ID: 9632380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
    Southgate C; Zapp ML; Green MR
    Nature; 1990 Jun; 345(6276):640-2. PubMed ID: 2190099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.